Back Back
Cell No. : Cell Name
RCB1468 : Btk^(-) DT40  update : 2024/01/17
CommentBtk deficient DT40 cells
Comment from the depositor
Terms and conditionsThere is no restriction regarding use for basic researches. In relation to commercial use and use for patent filing, first of all please contact the RIKEN BRC.
Order Form Order Form(C-0005.pdf)   MTA(C-0007.pdf)   MTA(C-0007p.pdf)  
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (
Basic information Depositor Kurosaki, Tomohiro
Originator Kurosaki, Tomohiro
Year of deposit 1998
Another name B7-10
Original cell DT40
Animal _avian < Birds
Tissue B cell
Classification mutant
Recombinant recombinant
Lifespan infinite
Morphology lymphocyte-like
Cellosaurus(Expasy) CVCL_1T45
deposit info
lot info
Medium Medium List
Culture type Suspension cells
Culture medium RPMI1640 (4mM Glutamine) + 10% FBS + 1% Chicken serum + 50μM 2-Mercaptoethanol
Culture method
Antibiotics Free
Passage method dilution
Culture information Passage cell No 1.5-2 x 10 5 cells/ml
Passage ratio 1 : 20 split
SC frequency Subculture : every 2 days
Temperature 39.5 ℃
CO2 concentration 5 %
Freeze medium 90% FBS + 10% DMSO
Freezing method Slow freezing
Mycoplasma (-)
Animal PCR OK
Others Freezing : 1.0-1.5x10 7 cells/ml/vial. Thawing : 1ml of cells into 20ml media. It is unnecessary to remove DMSO. Pass the next day.
deposit info
lot info
Reference information Reference 1
User's Publication 3

To topTop
2282  Takata M, Kurosaki T.  A role for Bruton's tyrosine kinase in B cell antigen receptor-mediated activation of phospholipase C-gamma 2.  J Exp Med  1996  184(1):31-40  PubMed ID: 8691147   DOI: 10.1084/jem.184.1.31

To topTop
User's Publication
14386  Hing ZA, Mantel R, Beckwith KA, Guinn D, Williams E, Smith LL, Williams K, Johnson AJ, Lehman AM, Byrd JC, Woyach JA, Lapalombella R.  Selinexor is effective in acquired resistance to ibrutinib and synergizes with ibrutinib in chronic lymphocytic leukemia  Blood  2015  125(20):3128-32  PubMed ID: 25838351   DOI: 10.1182/blood-2015-01-621391
18613  de Gorter DJ, Vos JC, Pals ST, Spaargaren M.  The B cell antigen receptor controls AP-1 and NFAT activity through Ras-mediated activation of Ral  J Immunol  2007  178(3):1405-14  PubMed ID: 17237388   DOI: 10.4049/jimmunol.178.3.1405
17351  Blois JT, Mataraza JM, Mecklenbraüker I, Tarakhovsky A, Chiles TC.  B cell receptor-induced cAMP-response element-binding protein activation in B lymphocytes requires novel protein kinase Cdelta  J Biol Chem  2004  279(29):30123-32  PubMed ID: 15138267   DOI: 10.1074/jbc.M402793200

Back Back Return Top Page